Back to MW MARSHALL WACE, LLP

IMRXIMRX
13 quarters

Position history for MWMARSHALL WACE, LLP's holdings in IMMUNEERING CORP

Yes. Marshall Wace holds 731,897 shares of IMRX (Immuneering), worth $3.7M, as of its Q2 2026 13F filing. It reduced the position by 1,264,688 shares (-63.3%) from Q1 2026. Marshall Wace has held IMRX since Q4 2024, across 7 quarterly 13F filings.

Current Value

$3.7M

Current Shares

731,897

Total Value Change

+$3.3M

Total Shares Change

+718,748

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
731,897
-63.3%
$3.7M0.0%$4.99
0
2026-Q1
Increased
2M
+180.5%
$10.5M0.0%$4.95
45
2025-Q4
Increased
711,875
+162.4%
$4.7M0.0%$6.73
43
2025-Q3
Decreased
271,304
-52.7%
$1.9M0.0%$6.75
0
2025-Q2
Decreased
573,864
-29.0%
$1.9M0.0%$3.53
0
2025-Q1
Increased
807,969
+3669.9%
$1.2M0.0%$1.64
41
2024-Q4
New
21,432
-
$47,1500.0%$2.25
28
2024-Q3
Exited
0
-100.0%
$00.0%$2.66
0
2024-Q2
New
384,075
-
$491,6170.0%$1.28
33
2022-Q4
Exited
0
-100.0%
$00.0%$4.85
0
2022-Q3
New
67,160
-
$962,0000.0%$13.12
35
2021-Q4
Exited
0
-100.0%
$00.0%$16.12
0
2021-Q3
New
13,149
-
$349,0000.0%$28.04
33

Other major holders of IMRX: PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used